| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/24/2002 | CA2413582A1 Use of a spla2 inhibitor for the treatment of sepsis |
| 01/24/2002 | CA2391791A1 Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substance dependence |
| 01/24/2002 | CA2384041A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 01/24/2002 | CA2382085A1 Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides |
| 01/23/2002 | EP1174427A1 Method for pulvirizing to fine powder |
| 01/23/2002 | EP1174148A1 Parenteral medicinal composition containing humanized monoclonal antibody fragment and method for stabilizing the same |
| 01/23/2002 | EP1174139A2 Use of mometasone furoate for treating airway passage and lung diseases |
| 01/23/2002 | EP1174138A2 Use of mometasone furoate for treating airway passage and lung diseases |
| 01/23/2002 | EP1174137A1 Patches containing buprenorphine hydrochloride |
| 01/23/2002 | EP1174136A2 Oral pharmaceutical dosage form containing a proton pump inhibitor |
| 01/23/2002 | EP1174135A2 Pharmaceutical composition for use in treatment of diabetes |
| 01/23/2002 | EP1174133A1 Pharmaceutical compositions containing amorphous mupirocin |
| 01/23/2002 | EP1174132A1 Percutaneous absorption preparations containing oxybutynin |
| 01/23/2002 | EP1174128A1 Vitamin-C preparation and process for preparation thereof |
| 01/23/2002 | EP1174127A1 Composition for targeted release of an actvie substance and process for producing such a composition |
| 01/23/2002 | EP1174126A1 Antibody and polyalkylene glycol-bonded liposome |
| 01/23/2002 | EP1174125A1 Intraocular infusion solution |
| 01/23/2002 | EP1174124A1 Percutaneous administration preparations |
| 01/23/2002 | EP1174121A1 Composition comprising a Sophora japonica extract and its cosmetic use |
| 01/23/2002 | EP1174110A1 Cosmetic or pharmaceutical solid composition comprising bis-acyl-amides |
| 01/23/2002 | EP1173600A2 Cationic peg-lipids and methods of use |
| 01/23/2002 | EP1173573A1 Method for down-regulating il5 activity |
| 01/23/2002 | EP1173561A2 Non-invasive method for detecting target rna |
| 01/23/2002 | EP1173521A1 Stable, aqueous dispersions and stable, water-dispersible dry powders of xanthophylls, and production and use of the same |
| 01/23/2002 | EP1173517A1 In situ forming hydrogels |
| 01/23/2002 | EP1173487A1 Haze-free cellulose ether capsules and process for making |
| 01/23/2002 | EP1173482A1 Insulin crystals for pulmonary administration |
| 01/23/2002 | EP1173367A1 Medicament carrier |
| 01/23/2002 | EP1173263A1 A method of spray drying and a plant therefore as well as a partic ulate material obtained by the method |
| 01/23/2002 | EP1173245A2 Compositions for aerosolization and inhalation |
| 01/23/2002 | EP1173244A1 Powder inhaler for combined medicament |
| 01/23/2002 | EP1173224A1 Polyethyleneimine:dna formulations for aerosol delivery |
| 01/23/2002 | EP1173222A2 Conjugate having a cleavable linkage for use in a liposome |
| 01/23/2002 | EP1173221A2 Releasable linkage and compositions containing same |
| 01/23/2002 | EP1173220A2 Targeting of infectious agents bearing host cell proteins |
| 01/23/2002 | EP1173219A1 Non-aqueous liquid shampoo composition |
| 01/23/2002 | EP1173218A1 Compositions for treatment of disorders of the oesophagus |
| 01/23/2002 | EP1173216A1 Pharmaceutical formulations |
| 01/23/2002 | EP1173215A1 Over-coated chewing gum formulations |
| 01/23/2002 | EP1173205A1 An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport |
| 01/23/2002 | EP1173197A2 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue |
| 01/23/2002 | EP1173189A1 Asialocytokines and treatment of liver disease |
| 01/23/2002 | EP1173181A2 Compositions comprising phosphodiesterase inhibitors for the treatment of sexual disfunction |
| 01/23/2002 | EP1173176A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 01/23/2002 | EP1173173A1 Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives |
| 01/23/2002 | EP1173171A1 Novel anticoagulant injectable composition |
| 01/23/2002 | EP1173158A1 Compounds useful in reducing the level of insulin like growth factor-1 (igf-1) in blood |
| 01/23/2002 | EP1173157A2 Treatment of trauma |
| 01/23/2002 | EP1173155A1 Gum pad for delivery of medication to mucosal tissues |
| 01/23/2002 | EP1173154A1 Chewing gum with dental benefits including calcium in a food grade acid |
| 01/23/2002 | EP1173153A1 Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants |
| 01/23/2002 | EP1173152A2 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers |
| 01/23/2002 | EP1173151A1 Dry, mouldable drug formulation |
| 01/23/2002 | EP1173145A1 Composition for cosmetic and dermatological skin care |
| 01/23/2002 | EP1173138A1 Cosmetic or pharmaceutical utilisation of nanoscalic metal soaps |
| 01/23/2002 | EP1173135A1 A method and apparatus for manufacturing dissolvable tablets |
| 01/23/2002 | EP1173127A1 Bandage having a scar treatment pad for scar management and scar repair |
| 01/23/2002 | EP1173071A1 Ginseng berry health products |
| 01/23/2002 | EP1173070A1 Cactus fruit health products |
| 01/23/2002 | EP1173069A1 Granular delivery system |
| 01/23/2002 | EP1094802B1 Pharmaceutical composition for injection based on paracetamol |
| 01/23/2002 | EP1043979B1 Compositions for the transdermal and dermal administration of biologically active agents |
| 01/23/2002 | EP1037613B1 Method for producing pharmaceutical formulations containing an extract |
| 01/23/2002 | EP1024787B1 Effervescent base |
| 01/23/2002 | EP1023055B1 Inhibition of crystallization in transdermal devices |
| 01/23/2002 | EP0888545B1 Super-paramagnetic particles with increased r 1 relaxivity, processes for producing said particles and use thereof |
| 01/23/2002 | EP0877602B1 Process for the production of powdered pulmonary surfactant preparations |
| 01/23/2002 | EP0840621B1 Hormone patch |
| 01/23/2002 | EP0752850B1 Pharmaceutical formulation |
| 01/23/2002 | EP0726771B1 Desferrioxamine oral delivery system |
| 01/23/2002 | CN2472717Y Compound bee gel film |
| 01/23/2002 | CN1332647A Method of depositing dry powder and dispensing device |
| 01/23/2002 | CN1332639A External preparation |
| 01/23/2002 | CN1332635A Controlled release formulation comprising GnRH-II |
| 01/23/2002 | CN1332630A Pharmaceutical composition for oral administration having therapeutic activity on gastrointestinal disorders |
| 01/23/2002 | CN1332627A Method of producing vitamin powder |
| 01/23/2002 | CN1332626A Inhalation system |
| 01/23/2002 | CN1332625A Nanocapsules and method of production thereof |
| 01/23/2002 | CN1332622A Method and apparatus for improved administration of pharmaceutically active compounds |
| 01/23/2002 | CN1332015A Freeze dried dyad live hepatitis A and parotitis vaccine |
| 01/23/2002 | CN1332012A Chinese medicine fumigant for treating vulval disease and its prepn |
| 01/23/2002 | CN1332008A Infusion pain stopping patch |
| 01/23/2002 | CN1332007A Powerful pain-stopping aerosol |
| 01/23/2002 | CN1332005A Meridian dredging and pain relieving ointment |
| 01/23/2002 | CN1331997A Antilpemic and thrombolytic pill |
| 01/23/2002 | CN1331996A Hepatitis B treaitng pill |
| 01/23/2002 | CN1331991A Chinese medicine bolus for treating cataract |
| 01/23/2002 | CN1331984A External-use trauma treating ointment |
| 01/23/2002 | CN1331983A Hyperosteogeny treating medicine |
| 01/23/2002 | CN1331982A Ointment (pellet) for eliminating wind-evil, diminishing inflammation and treating skin disease |
| 01/23/2002 | CN1331973A Prepn. of prostaglandin E1 urethra suppository |
| 01/23/2002 | CN1078248C Insulin-secreting cell lines, methods of production and use |
| 01/23/2002 | CN1078198C Process for extracting linolenic acid and producing soft capsules using linolenic acid |
| 01/23/2002 | CN1078080C Zinc-contg. haw oral liquid and its prepairng process |
| 01/23/2002 | CN1078079C Process for preparing Chinese medicine for treating gynopathy |
| 01/23/2002 | CN1078077C Non-scar neutral burn ointment and its prep. |
| 01/23/2002 | CN1078076C Instant powder for treatment of infantile splenico-gastric dysfunction and preparation thereof |
| 01/22/2002 | US6340698 Pharmaceutical solution, substantially free of cyclodextrin, for oral administration comprising itraconazole or saperconazole, acid and one or more alcoholic cosolvents |
| 01/22/2002 | US6340695 Rapid onset formulation |
| 01/22/2002 | US6340672 Parasiticidal formulation and a method of making this formulation |